Edition:
United Kingdom

Caplin Point Laboratories Ltd (CAPL.NS)

CAPL.NS on National Stock Exchange of India

428.45INR
10:23am GMT
Change (% chg)

Rs-8.35 (-1.91%)
Prev Close
Rs436.80
Open
Rs437.00
Day's High
Rs441.40
Day's Low
Rs425.00
Volume
12,384
Avg. Vol
56,951
52-wk High
Rs692.00
52-wk Low
Rs336.05

Latest Key Developments (Source: Significant Developments)

Says Caplin Point Laboratories And Hainan Jointown Pharmaceutical Signs JV Deal
Friday, 14 Sep 2018 

Sept 14 (Reuters) - Caplin Point Laboratories Ltd ::CO, HAINAN JOINTOWN PHARMACEUTICAL SIGNS JV DEAL TO ESTABLISH HAINAN JOINTOWN CAPLINPOINT PHARMACEUTICAL IN HAIKOU CITY.  Full Article

India's Caplin Point Labs Dec-Qtr Consol Profit Rises
Wednesday, 7 Feb 2018 

Feb 7 (Reuters) - Caplin Point Laboratories Ltd ::DEC QUARTER CONSOL NET PROFIT 375.2 MILLION RUPEES VERSUS PROFIT 237.6 MILLION RUPEES YEAR AGO.DEC QUARTER CONSOL REVENUE FROM OPERATIONS 1.42 BILLION RUPEES VERSUS 1.03 BILLION RUPEES YEAR AGO.  Full Article

India's Caplin Point Laboratories Sept-qtr consol profit rises
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Caplin Point Laboratories Ltd ::Sept quarter consol profit 355.7 million rupees versus profit of 224.1 million rupees year ago.Sept quarter consol revenue from operations 1.31 billion rupees versus 957.2 million rupees year ago.  Full Article

Caplin Point Laboratories gets U.S. FDA approval for ketorolac tromethamine injection
Wednesday, 20 Sep 2017 

Sept 20 (Reuters) - Caplin Point Laboratories Ltd :Says gets FDA approval for ketorolac tromethamine injection 30 mg/ml in U.S..Says ketorolac tromethamine injection will be manufactured at Caplin's FDA approved site.  Full Article

Cycle Pharmaceuticals gets FDA approval for Ketorolac Tromethamine injection
Tuesday, 19 Sep 2017 

Sept 19 (Reuters) - Cycle Pharmaceuticals::Cycle Pharmaceuticals receives FDA approval and launches Ketorolac Tromethamine injection 30mg/ml in the U.S..Cycle Pharmaceuticals receives FDA approval and launches Ketorolac Tromethamine injection 30mg/ml in the U.S..  Full Article

Caplin Point Labs approves re-appointment of Sridhar Ganesan as MD‍​
Monday, 7 Aug 2017 

Aug 7 (Reuters) - Caplin Point Laboratories Ltd ::Says approved re-appointment of Sridhar Ganesan as MD‍​.  Full Article

India's Caplin Point Laboratories June-qtr consol profit rises
Monday, 7 Aug 2017 

Aug 7 (Reuters) - Caplin Point Laboratories Ltd ::June quarter consol profit 363.2 million rupees versus profit 159.8 million rupees year ago.June quarter consol total income 1.27 billion rupees versus 864.5 million rupees year ago.  Full Article

India's Caplin Point Laboratories March-qtr consol profit more than doubles
Wednesday, 10 May 2017 

May 10 (Reuters) - Caplin Point Laboratories Ltd :March quarter consol net profit 334.1 million rupees versus 155.8 million rupees year ago.March quarter consol net sales 1.18 billion rupees versus 819.1 million rupees year ago.  Full Article

Caplin Point Laboratories gets EIR from USFDA for inspection at Gummidipoondi
Monday, 8 May 2017 

May 8 (Reuters) - Caplin Point Laboratories Ltd :Says gets EIR from USFDA for inspection at Gummidipoondi.  Full Article

Caplin Point Laboratories Dec-qtr profit rises
Monday, 6 Feb 2017 

Caplin Point Laboratories Ltd : Dec quarter net profit 177 million rupees versus profit 159.8 million rupees year ago .Dec quarter net sales 876.7 million rupees versus 755.2 million rupees year ago.  Full Article